Continues To Grow Owing To the Increasing Rate of Needle Phobia among Individuals, the Risk of Getting Infected By the Usage of Needles

 

Needle free Injection System Market

A needle-free injection system is a popular treatment method for many diseases. These devices have been around since at least the 1980s, and they continue to remain a solid option for many medical practices. Some patients may have problems with certain brands or types of these products, which is why it's critical to ask the healthcare provider about alternative products if someone is having trouble with one that their doctor prescribed. People want to ensure that they get the best product for their needs, and that means being careful about choosing the right one for them and their treatment.

The main component in an FDA-approved needle-free injection system device is compressed gas (or solution) that's injected into the injection site. The compressed gas isn't meant to harm the patient, but rather to provide a safer, more hygienic way to administer injections. This kind of device features a reusable rubber needle that's designed in a way that allows it to be inserted into the injection site without any risks or pain involved. The idea is that the healthcare provider will be able to give a more thorough injection that will reduce the risk of infection or other complications.

Market Dynamics                                  

The main factor influencing the growth of the needle-free injection system market is the increasing cases of needle-associated injuries and rapidly growing needle phobia among adults and children. For instance, according to the United Kingdom National Health Service, needle phobia affects around 1 in 10 individuals. Approximately 22% of the adult population in the world has needle phobia. Chronic diseases such as diabetes require a daily dosage of insulin that can be self-administered through needles. This can result in health injury owing to lack of adherence and lack of confidence. The increase in research related to biologics and biosimilar is another factor estimated to propel the market growth of the needle-free injection system market. Additionally, the growing incidence of communicable diseases that can be caused by needles and the increase of the geriatric population worldwide are estimated to augment the market growth.

However, the cost of needle-free injections is the main restraining factor hindering the growth of needle-free injection systems market.

This market is distributed in five regions that include Asia-Pacific, North America, Europe, Africa, and the Middle East, and Latin America. Among these, North America is expected to a significant share of the needle-free injection system market owing to the high prevalence of chronic diseases such as cancer and diabetes in the region. For instance, according to the Centers for Disease Control and Prevention, in 2020, around 34.2 million U.S. residents were suffering from diabetes. The needle-free injection system market in the Asia Pacific is estimated to witness significant growth owing to the rise of the geriatric population in the region and favorable government health policies.

Competitive Analysis

Key players operating in the needle-free injection system market include Crossject SA, European Pharma Group, Valeritas, Inc., National Medical Products Inc., INJEX Pharma AG, PenJet Corporation, Medical International Technology, Inc., Bioject Medical Technologies Inc., PharmaJet, Zogenix, Portal Instruments, Inc., Endo International plc, and Antares Pharma, Inc.

In October 2020, PharmaJet developed a needle-free injection technology to deliver COVID-19 vaccines which were developed by the University of Cambridge. Likewise, in February 2021, Zydus Cadila developed ZyCoV-D, a DNA vaccine that can be assessed to patients through a needle-free injection system.

Rising Number of Minimally Invasive Surgeries around the Globe Is Driving the Growth of the Medical Coating Market

 

Medical Coating Market

Medical coatings are a new form of protective gear for health care professionals. These coatings help to protect from the potentially harmful effects of chemicals and treatments that are used on patients in the medical profession. They help prevent permanent discoloration of patients' skin and other reactions such as blistering, stinging, swelling and itching, burning, redness and sensitivity. Coatings come in a variety of different materials, styles, colors, and thicknesses and serve various purposes. Medical coatings can be a type of barrier or a layer of protection between an affected area and external conditions such as heat and moisture

An increasing geriatric population around the globe is driving the need for healthcare services. This in turn augmenting the growth of the Medical Coating Market. According to the United Nation, by 2050, one in six people in the world will be over age 65 (16%), up from one in 11 in 2019 (9%). By 2050, one in four persons living in Europe and Northern America could be aged 65 or over. Moreover, the growing demand for minimally invasive surgical procedures is another key factor propelling the growth of the market. iData’s robotic surgery statistics show that in 2017, minimally invasive surgeries accounted for approximately 86% of total robotic surgeries performed in the United States. Thus, the growing number of minimally invasive surgeries is propelling the growth of the Medical Coating Market.

North America is projected to gain significant growth over the forecast period and this is attributed to the increasing launch of innovative medical coating products by key players in the region. For instance, in September 2019, Biocoat, Inc., a specialty manufacturer of hydrophilic biomaterial coatings for medical devices announced that the company has launched an ISO-certified, full-service on-site facility for the application of its HYDAK® coatings to its unique medical devices.

Key Developments:

1.      In September 2019, Biocoat (Horsham, PA) has launched a full-service, on-site facility for the application of its Hydak coatings to customer’s devices. The new facility will save medical device companies time and money

2.      In June 2020, Bio-Gate AG, a provider of technologies for health and hygiene, has signed a cooperation agreement with Aesculap AG for the antimicrobial coating of revision implants for knee and hip systems.

3.      In August 2019, an international research project, led by the University of Sydney’s School of Aerospace in collaboration with UMC Utrecht and the Heart Research Institute and three other research partners, has developed a new plasma coating for bone implants with the aim of decreasing complications.

Emergence of Covid-19 and Lunch of New Products to Augment Growth of Steam Autoclave Market

 

                                                                     Steam Autoclave

Autoclaves are also known as steam sterilizers and are used to expose each item to direct steam contact at the required temperature and pressure for the specified time. They are used for healthcare or industrial applications to eliminate the protein structure of the bacteria and spores.

Market Dynamics

Compatible of steam autoclaves for crisis strategy decontamination of N95 respirators is expected to propel growth of the global steam autoclave market. For instance, in October 2020, 3M, a U.S-based multinational conglomerate corporation, announced that Belimed steam autoclaves are compatible for crisis strategy decontamination of specific single-use N95 Respirators. Moreover, launch of biological indicators for steam autoclaves is also expected to aid in growth of the market. For instance, in December 2020, Steris Corporation, a U.S-based medical equipment company, launched Spordex Self-Contained Biological Indicator Ampoules to confirm sterilization of liquids in steam autoclave cycles.

Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the global steam autoclave market. For instance, globally, as of 4:03pm CET, 1 March 2021, there have been 113,820,168 confirmed cases of COVID-19, including 2,527,891 deaths, reported to the World Health Organization. Moreover, high prevalence of hospital-acquired infections is also expected to aid in growth of the market. For instance, according to an observational epidemiological study of intra-abdominal infections published in December 2019, in NEJM Journal Watch, of the 2621 critically ill adults with intra-abdominal infections at 309 international centers between January and December 2016, 32% were community-acquired, while 68% were hospital-acquired.

The global steam autoclave market is witnessing entry of new market players. For instance, in October 2019, Chalmers Group of Companies, a privately owned Canada-based corporation, formed Spire Integrated Solutions, a manufacturer and services provider for steam sterilizers, washing equipment, refrigeration products, and ancillary stainless-steel equipment featuring non-proprietary parts.

The global steam autoclave market is also witnessing several M&A activities. For instance, in October 2019, Chalmers Group of Companies acquired LYNX Product Group, a provider of steam sterilizers, washing equipment, refrigeration products, and ancillary stainless-steel equipment featuring non-proprietary parts.

Competitive Analysis

Major players operating in the global steam autoclave market include, Steelco S.P.A., Dental X spa, Tuttnauer Co. Ltd., BMM Weston Holdings Ltd., Getinge, BMT Medical Technology s.r.o., Belimed AG, ERYIGIT A.S., and Hanshin Medical Co., Ltd.

Major players operating in the global steam autoclave market are focused on R&D to expand their product portfolio. For instance, in 2019, Getinge launched GSS610H, a steam sterilizer.

Medical Aesthetics Market Continues to Grow Owing to the Rising Demand for Surgical Procedures Related to Better External Appearances, Wellbeing, and Visible Skin Changes among Individuals

 

Medical Aesthetics

Medical aesthetics is a fairly broad field that covers several different, often overlapping sub-specialties. These include endocrinology, gynecology, pathology, radiology, gastroenterology, health care, obstetrics/maternity, orthopedics, pediatrics, physiology, psychology, statistics, and pharmacology. The field of medical aesthetics is increasingly expanding due to increasing numbers of people who have an interest in looking better and feeling better about their appearance. This interest has resulted in an expansion of the field into several subspecialties, which are described below.

One of the top five surgical aesthetic procedures is liposuction. Liposuction is a procedure used to remove pockets of fat from different parts of the body to improve facial features, such as an extra small smile, sagging skin around the eyes or lips, or fat deposits in the neck or waist. Other liposuction procedures include using liposuction to change the size and shape of tattoos, removing skin tags, wart formation on the face, flattening abdominal fat, reshaping the breasts after pregnancy, removing wrinkles, and improving the skin texture around the mouth, chin, and neck. Other surgical aesthetic procedures include laser lipolysis, adjustable gastric banding, lipoplasty, blepharoplasty, neck lift, chin and jowl reduction, laser facial resurfacing, and Botox injections.

Market Dynamics                                  

The main factor influencing the medical aesthetics market is the growing surgical procedures worldwide for advanced personal appearance. For instance, according to the Centers for Disease Control and Prevention, around 130,000 facelifts are performed in the U.S. and the numbers are increasing annually. According to Cosmetic Surgery Solicitors, the U.S. and Brazil accounted for more than 28.4% of cosmetic producers in the world in 2018. The top five surgical procedures that are done across the globe are ear surgery, fat grafting, rhinoplasty, gynecomastia surgery, liposuction, and eyelid surgery. Male patients are also continuously focusing on aesthetic procedures owing to the better results with lesser discomfort and downtime. This is estimated to propel the market growth of medical aesthetics. However, the social stigma, which is associated with aesthetic procedures and strict safety regulations related to these procedures can act as a main restraining factor hindering the growth of the medical aesthetics market.

This market is distributed in five regions that include Asia-Pacific, North America, Europe, Africa, and the Middle East, and Latin America. Among these, North America is expected to a significant share of the medical aesthetics market owing to the rapidly growing aesthetic procedures in the region. For instance, according to the American Society of Plastic Surgeons (ASPS), in the U.S., in 2018 there were over 17.7 million cosmetic surgeries performed. The medical aesthetics market in the Asia Pacific is estimated to witness significant growth owing to the rise of medical aesthetic procedures and products in the region.

Competitive Analysis

Key players operating in the medical aesthetics market include Solta Medical. Inc, Syneron Medical, Ltd., Galderma S.A., PhotoMedex, Inc., ZELTIQ Aesthetics, Inc., Lumenis Ltd., Mentor Worldwide LLC, Alma Lasers, Ltd., Allergan, Inc., and Cynosure, Inc.

In February 2021, Sidra Medicine introduced the Aesthetic Surgery and Medicine clinic for women.

Increasing Demand for Emergency Medical Supplies to Augment the Medical Supplies Market Growth

 

Medical Supplies

Medical devices play an important role in the delivery of many health care services. Medical supplies refer to any item (basic medical products) that is necessary for treating injury or illness. In the medical parlance, medical supplies generally are understood to mean items that are low cost, disposable, easily available, and in high enough quantity so that the buying department has enough standing orders to ensure the supply of the items when they are in demand.

Market Dynamics:

Increasing prevalence of chronic diseases across the globe, especially in North America, is expected to propel the growth of the medical supplies market. According to the Centers for Disease Control and Prevention (CDC), chronic diseases such as diabetes, cancer, and heart disease are the leading causes of death and disability in the United States.

Moreover, proactive government initiatives, increasing demand for infection control measures to curb the occurrence of hospital-acquired infections, the rising number of surgical procedures, and increasing demand for medical supplies are expected to augment the growth of the medical supplies market. According to CDC, hospital-acquired infections account for an estimated 1.7 million infections and 99,000 associated deaths each year in American hospitals alone.

Increasing demand for emergency medical supplies due to the emergence of COVID-19 is expected to offer lucrative growth opportunities for players in the medical supplies market. For instance, according to the World Health Organization (WHO), worldwide, as of 1 March 2021, there have been 113,820,168 confirmed cases of COVID-19, including 2,527,891 deaths.

Competitive Analysis:

Major players operating in the medical supplies market are Becton, 3M Company, Baxter International Inc., Boston Scientific Corporation, Thermo Fisher Scientific Inc., Johnson & Johnson, Halyard Health, Inc., Cardinal Health, Inc., Dickinson and Company, and B. Braun Melsungen AG among others.

Major players in the market are adopting inorganic growth strategies, such as business expansion, product launch, merger and acquisition, etc., to retain their position in the market. For instance, in June 2020, Fresenius Medical Care started a new production line for dialysis fluids at its St. Wendel, Germany, plant. The new production line is the plant’s fifth production line for dialysis fluids used in the treatment of acute and chronic kidney disease.

In February 2020, Baxter International Inc. announced 510(k) clearance from the U.S. Food and Drug Administration for a new generation of its Peri-Strips Dry with Veritas Collagen Matrix (PSDV) product, known as PSDV with Secure Grip.

In August 2019, Boston Scientific Corporation announced the acquisition of BTG plc.to offer best-in-class technologies and strengthened commercial infrastructure.

Patient Warming Devices Market is Expected to Witness Robust Growth with Smiths Medical Inc. Introducing Level 1 Convective Warmer, a Next-Generation High-Flow Convective Warmer

 

Patient warming devices come in many forms, each designed for a specific purpose. For example, some devices are made for offices that are out of the way or for doctor offices that are smaller in size. In addition, these applications are very easy to operate and can be used without requiring a great deal of training on the part of the patient or the medical professional using the device. However, there are certain devices that are extremely efficient and are recommended by both practitioners and medical associations across the country.

Increasing number of surgical procedures is expected to drive growth of the global patient warming devices market. According to the National Health Statistics Reports, in 2017, around 48.3 million surgical and nonsurgical procedures were performed in the U.S. with around 25.7 million ambulatory surgery procedures being performed in hospitals, while 22.5 million being performed in ambulatory surgery centers (ASCs). Patient warming devices are widely used in surgical procedures, which cover before and after surgery. As a result of this, the demand for patient warming devices has increased significantly. Hence, these factors are expected to drive growth of the global patient warming devices market. Furthermore, growing geriatric and infant population is expected to propel the global patient warming devices market growth in the near future. According to the World Health Organization (WHO), the global geriatric population is expected to account for around 22% of the global population by 2050.

Presence of alternative methods and stringent regulatory framework is expected to hinder the global patient warming devices market growth in the near future. Among regions, North America is expected to witness significant growth in the global patient warming devices market are increasing number of cardiac surgeries and growing healthcare expenditure in the U.S. Furthermore, Asia Pacific is expected to register a robust growth rate, owing to the presence of high unmet needs in the region.

Major companies involved in the global patient warming devices market 3M Company, The37Company, Belmont Medical Technologies, Stryker Corporation, Biegler GmbH, Smiths Medical Inc., Gentherm Inc., Sarstedt AG & Co. KG, GE Healthcare, Philips Healthcare, and ZOLL Medical Corporation.

For instance, in March 2019, Smiths Medical Inc. introduced Level 1 Convective Warmer, a next-generation high-flow convective warmer that offers a safe and simple thermal care solution to maintain body temperature during every state of the surgery.

Medical Ceramics Market is Expanding Rapidly with Zimmer Biomet Holdings, Inc. Completed the Acquisition of A&E Medical Corporation for US$ 150 Million

 

Medical ceramics are ceramics that have the properties to be used as the direct medium of medical procedures. They are made from a number of different materials including porcelain, enamel, ceramic, polymers, and other materials. The ceramic material is used to serve the purpose of impregnating the substances on the affected part so that they get affected by the required heat and are changed into a non-toxic and safe substance.

Increasing demand for implantable devices is expected to drive the growth of the global medical ceramics market. The demand for implantable devices offer additional advantages including the ability to selectively activate grouping of fibers within the nerve. Major companies operating in the market are focused on research and development activities, in order to gain a significant edge in the competition. For instance, in December 2020, W. L. Gore and Associates, Inc. received the U.S. Food and Drug Administration (FDA) approval for its Gore Excluder Comfortable (EXCC) AAA Endoprosthesis to treat patients with aneurysm of the infrarenal abdominal aorta. Furthermore, in December 2020, Boston Scientific Corporation received the U.S. FDA approval for Vercise PC and Vercise Gevia Deep Brain Stimulation (DBS) Systems, an implantable device to reduce signs and symptoms of advanced levodopa-responsive Parkinson’s disease. Hence, such factors are expected to drive growth of the global medical ceramics market. Furthermore, increasing demand for medical ceramics in plastic surgeries is expected to propel the global medical ceramics market growth in the near future.

Stringent clinical and regulatory processes and product recalls are expected to restrain growth of the global medical ceramics market. Lack of skilled professionals and concerns regarding reparability are expected to hinder the market growth in the near future. However, rapid growth of the healthcare sector can present lucrative growth opportunities for market players. Among regions, North America is expected to witness significant growth in the global medical ceramics market. This is owing to high usages of implantable medical devices and diagnostic imaging equipment in the region. Furthermore, Asia Pacific is expected to register a robust growth rate, owing to rising demand for medical devices in emerging economies such as India and China.

Major companies involved in the global medical ceramics market are CoorsTek Inc., DePuy Synthes, Zimmer Holdings, Inc., Morgan Advanced Materials, Straumann, Nobel Biocare Services AG, Stryker, 3M ESPE, Kyocera Corporation, Advanced Cerametrics Inc., H.C. Starck GmbH, Advanced Ceramics Research, Inc., and APC International Ltd.

For instance, in December 2020, Zimmer Holdings, Inc., a provider of musculoskeletal healthcare solutions, acquired A&E Medical Corporation, a subsidiary of Vance Street Capital Portfolio Company, for US$ 150 million in cash.

Increasing Prevalence of Oral Diseases to Augment the Dental Membranes and Bone Graft Substitutes Market Growth

 

Dental Membranes and Bone Graft Substitutes are used in bone graft surgeries. Dental bone grafting is a medical procedure that replaces missing tooth lost due to a dental disease, an accident, or old age. Dental membrane and bone graft substitutes are extensively used in implant procedures that require additional bone support.

Market Dynamics:

Increasing prevalence of dental/oral diseases, such as oral cancer, cavities (tooth decay), and gum disease, is expected to propel the growth of the Dental Membranes and Bone Graft Substitutes Market. For instance, oral disease affects 3.9 billion people worldwide, according to FDI World Dental Federation. Moreover, according to the Centers for Disease Control and Prevention (CDC), more than 1 in 4 (26%) adults in the United States have untreated tooth decay and around half (46%) of all adults aged 30 years or older show signs of gum disease.

Moreover, the increasing patient population coupled with the growing geriatric population is expected to augment the growth of the dental membranes and bone graft substitutes market. For instance, according to the World Health Organization (WHO), by 2050, the world's population aged 60 years and older is expected to total 2 billion, up from 900 million in 2015.

Increasing demand for bone graft substitutes is also expected to fuel the growth of the dental membranes and bone graft substitutes market. For instance, in 2019, Zimmer Biomet launched OsseoGuard non-resorbable dental membranes and sutures to expand its product portfolio.

However, high cost of bone graft procedures and stringent government regulations are expected to restrain the dental membranes and bone graft substitutes market growth.

Competitive Analysis:

Major players operating in the dental membrane and bone graft substitute market are Citagenix, Inc., Dentsply Sirona Inc., Institut Straumann AG, RTI Surgical Holdings, Inc., LifeNet Health, BioHorizons, Inc., ACE Surgical Supply Company, Inc., Geistlich Pharma North America Inc., and Zimmer Biomet Holdings, Inc.

Major players in the market are adopting various strategies, such as partnership, collaboration, merger and acquisition, etc., to strengthen their market presence. For instance, in September 2019, Straumann and Modern Dental Group Limited teamed up to create Peak Dental Solutions Hong Kong Ltd., a distribution company that will serve the dental communities in Hong Kong and Macau.

Moreover, in March 2018, Dentsply announced the signing of a definitive agreement to acquire OraMetrix, a leading industry provider of innovative 3-D technology solutions improving the quality and efficiency of orthodontic care.

Rise in Number of Cardiovascular Surgery around the Globe is Impelling the Growth of the Micro Guide Catheters Market

 

Micro guide catheters are used in order to guide the urethra so that you can have an easy time inserting your pet's urethra and not be worried about any kind of blockage at all. There are many types of these devices available in the market. Some of these are manual tube and electric as well. Many people prefer to use micro guide catheters because they are made very simply and with great ease of use.

A growing number of surgical procedures for treating cardiovascular diseases is fueling the growth of the micro guide catheters market. According to the American College of Cardiology Foundation, in 2017, emergency medical services-assessed out-of-hospital cardiac arrest occurred in an estimated 356,461 Americans; emergency medical services treatment was initiated in 52%. In the United States in 2019, coronary events are expected to occur in about 1,055,000 individuals, including 720,000 new and 335,000 recurrent coronary events. The increasing development of modern disposable catheters that are safer and more comfortable to insert is further projected to foster the growth of the micro guide catheters market.

North America is projected to gain significant growth over the forecast period and this is attributed to the continuous launch of innovative products by ley players in the region. For instance, in March 2017, Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and the U.S. commercial launch of the TrapLiner Catheter. The TrapLiner Catheter was developed by Vascular Solutions Inc., which was acquired by Teleflex.

Key Developments:

1.      In May 2019, Medtronic announced the launch of the Telescope guide extension catheter, to provide backup support and access to distal lesions. This marks the med-tech major’s foray into the guide extension catheter market.

2.      In August 2018, S3V Vascular Technologies Private Limited, a medical devices manufacturing company launched Nextgen PTCA (Percutaneous Transluminal Coronary Angioplasty) Balloon Catheters into the domestic market. PTCA is a minimally invasive procedure to open up blocked coronary arteries, allowing blood to circulate unobstructed to the heart muscle.

3.      In March 2020, Zeus Industrial Products, Inc. (Zeus), a polymer solutions provider and material science innovator has expanded its StreamLiner™ family of thin, extruded PTFE catheter liners. The new StreamLiner OTW UT, the thinnest extruded liner yet, offers a nominal wall thickness as low as 0.0004" (0.0102 mm) with a tolerance of +/- 0.0002" (0.0051 mm).

Emergence of Covid-19 to Boost Adoption of Protein Assays Market to Detect Antibodies against Various Proteins of Coronavirus

 

The Bradford protein assay is used extensively for analysis of proteins in many applications including drug discovery, food safety, and medical diagnostics. The assays are also useful in the analysis of various proteins complexes that have been detected by various methods. The concept of this assay is based on the interaction of protein molecules with fluorescent dye under acidic conditions resulting in a bluish color shift from blue to red. This process actually determines the presence of all the basic amino acids, arginine, glycine and histidine that leads to formation of the co-enzymatic protein complex. It can be used in combination with other methods for evaluation of protein content.

Market Insights

Significant growth in the pharmaceutical sector is expected to propel growth of the global protein assays market. For instance, according to The European Federation of Pharmaceutical Industries and Associations’ Key Data 2019, the pharmaceutical sector in Europe invested US$ 19, 509 million in 2000, which increased to US$ 39,895 million (est.) in 2018. Moreover, launch of graphene-based electrochemical biosensors is also expected to aid in growth of the market. For instance, in February 2018, Nanomedical Diagnostics launched Graphene Biosensor- FLEX, which can be easily integrated with company’s Agile R100 protein assay system to increase the efficiency of the drug discovery process.

Among regions, Europe is expected to witness significant growth in the protein assays market, owing to growing pharmaceutical sector. For instance, according to The European Federation of Pharmaceutical Industries and Associations’ Key Data 2019, the pharmaceutical sector in Europe was valued at US$ 139, 287 million in 2000, which increased to US$ 284, 028 million (est.) in 2018.

Emergence of Covid-19 is expected to boost adoption of protein assays to detect antibodies against various proteins of coronavirus. For instance, in August 2020, Eurofins launched multiple serological assay solutions to detect antibodies targeted against the Nucleocapsid protein of the novel coronavirus.

Competitive Analysis

Major players operating in the global Protein Assays Market include, Thermo Fisher Scientific Inc., GE Healthcare, Merck KGaA, Bio-Rad Laboratories, Inc., Lonza Group, Abcam plc, PerkinElmer Inc., Bio-Techne, BioVision Inc., Eurofins, AYOXXA Biosystems GmbH, Cell Signaling Technology, Inc., and Geno Technology Inc.

January 2019: AYOXXA Biosystems GmbH signed a research agreement with one of the leading pharmaceutical companies (details were not disclosed) for the development of a series of low volume, high sensitivity multiplex protein assays intend to validate protein biomarkers in the field of ophthalmology.

Increasing integration of Healthcare IT System to Foster the Growth of the Medical Computer Cart Market

 

Medical computer carts provide total instrumentation flexibility, high-speed data transfer rates, and complete instrumentation compatibility with other brands and applications. Medical computer carts help medical professionals manage their workflow while reducing training costs, reducing operating costs, and simplifying patient care. A medical computer cart solution can be implemented at any level of the healthcare operation and is designed to seamlessly coordinate with existing medical office software systems. The carts are available for use in most medical facilities including rehabilitation clinics, doctor offices, and surgical centers, as well as pharmacies and hospital outpatient departments.

Increasing use of medical carts across a wide range of applications such as medical recording, training, charting, nursing education, and medicine dispensing is predominantly fueling the growth of the medical computer cart market. Growing global healthcare spending by the government is again fueling the growth of the market. According to the World Health Organization, global spending on health continues to rise. It was US$ 7.8 trillion in 2017 or about 10% of GDP and $1,080 per capita – up from US$ 7.6 trillion in 2016. Moreover, the growing incidence of musculoskeletal injury (MSI) coupled with the increasing adoption of electronic medical records (EMR) is further anticipated to propel the growth of the medical computer cart market.

From the geographical point of view, North America is projected to gain significant growth over the forecast period and this is attributed to the presence of a well-established healthcare sector and the availability of integrated healthcare IT systems. According to the National Center for Health Statistics, 85.9% of office-based physicians are using any EMR/EHR system and 79.7% of office-based physicians have a certified EMR/EHR system.

Key Developments:

1.      In August 2020, Capsa Healthcare announced the launch of the new Trio™ mobile computing workstation. Trio is Capsa's latest generation point-of-care platform to mobilize e-health records and support efficient and accurate medication management

2.      In August 2019, Advantech, a provider of medical computing systems and services has announced the latest addition to its AMiS product line – the AMiS-50E computerized medical cart with iPS-M420S power system. It has been designed to support a wide range of healthcare applications, AMiS-50E features a 21” panel PC powered by a 7th generation Intel® Core™ i5/i7 processor for high-performance computing.

3.      In February 2017, Enovate Medical Introduces R7.0 All-In-One computer sets a new performance standard for mobile EHR workstations designed specifically for clinical settings.

The Global Gynecological Devices Market Continues To Grow Owing To The Rising Demand For Regular Gynecological Checkups And Increasing Awareness On Women’s Health And Hygiene

 

A gynecological device is a medical device that is used to promote female health or to protect and preserve reproductive health for females. This is a very broad category and includes products such as watches, calculators, bandages, and hygienic towels. While many of these products have been clinically tested and found to be safe for female health, there are still a few devices in the market that pose threats to female reproductive health. Gynecological devices are usually fall into three categories: medical devices, biological safety devices, and mechanical devices. Medical devices are those that prevent the risk of injury or trauma to a woman's reproductive organs from medical interventions. Biologic safety devices are those that protect a female's health by promoting female reproductive health. Finally, mechanical devices are those that help maintain a woman's reproductive health and allow her to achieve or reach their desired fertility or pregnancy. The use of any of these unsupervised or unsafe medical procedures poses a risk to a woman's reproductive health and should be avoided at all costs.

Market Dynamics                                  

The main factors driving the growth of gynecological devices market are the rapid increase of gynecological diseases such as uterine fibroids, endometriosis, and vaginitis and the introduction of new innovative gynecological devices in the market. For instance, according to the U.S. National Center for Biotechnology Information, approximately 97 per 1000 women suffer from gynecological diseases in the U.S., among which approximately 53 per 1000 women suffer from menstrual disorders. Rising awareness about gynecological health and preventive check-up to avoid sexually transmitted diseases (STD) is expected to boost the market growth. Moreover soaring numbers of surgical procedures such as female sterilization, endoscopy, laparoscopy, and ablation are driving the demand for gynecological devices.

However strict regulatory orders by governmental bodies across the globe related to the safety of gynecological devices and products are the main restraining factor hindering the growth of the market. Moreover, the rapid increase of alternative therapies such as improved drug therapy and personalized medicines are also expected to hinder the market growth.

This market is distributed in five regions that include North America, Europe, Asia-Pacific, Middle East, and Africa, and Latin America. Among these, North America is estimated to hold a bigger share of the gynecological devices market owing to the high rate of awareness related to the availability of diagnostic treatments and tests, increasing reimbursement full coverage, and well equipped medical infrastructure. For instance, according to the Centers for Medicare & Medicaid Services in 2019, there were approximately 43,000 full-time and board-certified OB-GYN practitioners in the U.S. The market in the Asia Pacific is estimated to witness significant growth in the market owing to the presence of key players in the region and governments' initiative to control the rapid expansion of the population.

Competitive Analysis

Key players operating in the gynecological devices market include Olympus Corporation, Medtronic, Richard Wolf GmbH, Boston Scientific Corporation, Karl Storz GmbH& Co. KG, Cooper Surgical, Inc., Stryker Corporation, MedGyn Product Inc., Hologic, Inc., and Ethicon, Inc.

In 2018, Lina Medical launched the OperaScope, which can be used to diagnose and treat hysteroscopy. In 2020 Creek Women's Health and Lupin Pharmaceuticals Inc. agreed to add Nella women’s health product to Lupin's portfolio.

Increasing Incidence of Sports Injuries and Road Accidents to Augment the Prosthetic Legs Market Growth

 

In medical science, a prosthetic limb is an artificially created device that substitutes a damaged body part that may be damaged through injury, disease, or simply a natural condition at birth. Prosthetic limbs are designed to fully restore the functional roles of a missing body part so as to provide full mobility and independence to the person affected. Apart from birth defects, various medical conditions such as diabetes, cancer, traumatic injuries, and circulation problems can lead to amputation of limbs.

They can be constructed from a wide variety of materials and come in a variety of styles. Most importantly, they have been approved for therapeutic use in humans under the terms of the United States Food and Drug Administration (FDA). Although most patients choose to wear prosthetic legs in their home, there are several reasons why a professional should prescribe and supply them to an amputee.

Market Dynamics:

Increasing incidence of sports injuries and road accidents worldwide, the increasing prevalence of osteosarcoma, and rising number of diabetes-related amputations are expected to propel the growth of the prosthetic legs market. For instance, according to the World Health Organization (WHO), around 1.35 million people die each year as a result of road traffic crashes. Road traffic accidents are the 9th leading cause of deaths worldwide.

Moreover, increasing prevalence of peripheral vascular disease (peripheral arterial disease and trauma is the second-leading cause of limb loss) is also expected to augment the prosthetic legs market growth. For instance, according to the Centers for Disease Control and Prevention, around 6.5 million people age 40 and older in the United States have peripheral vascular disease.

The prosthetic legs market is witnessing significant merger and acquisition (M&A) activities. For instance, in June 2020, Ossur completed acquisition of College Park Industries, a provider of lower and upper limb prostheses and supporting services. Moreover, in 2019, Ossur acquired the prosthesis technology from SpringActive to develop powered ankle prosthesis

Competitive Analysis:

Major players operating in the prosthetic legs market are The Ohio Willow Wood Co., Otto Bock HealthCare GmbH, Hanger Inc., Touch Bionics Inc., Ossur, and Blatchford Ltd.

Major players in the market are involved in different business strategies such as product launch, etc. to strengthen their product portfolio. For instance, in March 2019, NYQ announced the launch of the UNYQ Socket, a 3D printed prosthetic leg socket, providing individuals with the perfect product to complement their prosthetic cover.

The Global Ostomy Drainage Bags Market Continues To Grow Owing To the Increase of Patients Diagnosed With Crohn's Disease, Ulcerative Colitis, Bladder Cancer, and Colorectal Cancer

 

Ostomy drainage bags are a type of waste matter removal system from the body that provides the collection of surplus fecal matter in a surgical diverted organ such as the bladder, colon, or urethra. Ostomy drainage bags are commonly used in open-heart surgery, where the bag is used to collect excess blood that accumulates in the left ventricle during a heart attack. The bags are also used in the gastrointestinal tract in cases where stress caused by surgical procedures or digestive diseases may affect the smooth function of the intestines. Ostomy drainage bags are specifically designed to be placed under the skin so that the patient can be easily removed from the bed. This facilitates better patient care and lesser infections related to the removal of the gut. The demand for ostomy drainage bags has been rising gradually as they are highly effective in performing many ostomy procedures such as perineal urological placement, pre-surgical colonoscopy, pre-operative imaging of abdominal CT images, and many more.

Market Dynamics                                  

The medical use of these bags can be divided into two major categories, single-piece system, and two-piece system. A Single-piece system consists of one pouch with a single drainage tube inside the bag and another tube leading to an external collection bag. A two-piece system involves a bag with a single tube leading to an external drainage bag and another tube leading to an internal collection bag; thus facilitating easy movement of stools.

The main factor driving the growth of the ostomy drainage bags market is the increased cases of Crohn's disease, ulcerative colitis, bladder cancer, and colorectal cancer all over the world. For instance, according to the American Cancer Society, in 2020, in the U.S. approximately 104610 people were diagnosed with colon cancer and approximately 43340 were diagnosed with rectal cancer.

However, patients who have undergone ostomy procedures sometimes experience various types of issues or discomforts. According to a report by the National Center of Biotechnology Information (NCBI), approximately 20% to 70% of patients experience complications related to stoma after the surgery process is over. This is acting as the major restraining factor hindering the growth of the market.

This market is distributed in five regions that include North America, Europe, Asia-Pacific, Middle East, and Africa, and Latin America. Among these, Europe is estimated to hold a bigger share of the ostomy drainage bags market owing to the growth of disposable income groups which is leading to the increased number of people able to afford the costly ostomy procedure. The Asia Pacific is also expected to witness significant growth in the market owing to the rising prevalence of colorectal cancer in emerging economies such as South Korea, the Philippines, Turkey, and Indonesia.

Competitive Analysis

Major players operating in the global ostomy drainage bags market include Flexicare Medical Ltd., Coloplast A/S, Salts Healthcare Ltd., B. Braun Melsungen AG, ConvaTec Group plc, Pelcin Healthcare Ltd., Hollister Incorporated, ALCARE Co., Ltd., Torbot Group Inc, and Welland Medical Ltd.

In September 2019, ConvaTec Group Plc acquired Southlake Medical Supplies Inc., an ostomy drainage bags supplier.